drugset / Trial / NCT01433406
Summary
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with TAK-875 in diabetic patients.
Timeline
- Start
- 2011-10
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fasiglifam | Small molecule | 25 mg | — |
| Subject | Fasiglifam | Small molecule | 50 mg | — |